Header Logo

Connection

HOP S. TRAN CAO to Liver Neoplasms

Back to Details
This is a "connection" page, showing publications HOP S. TRAN CAO has written about Liver Neoplasms.
HOP S. TRAN CAO
Connection Strength
6.531
Liver Neoplasms
  1. Advancing Robotic Liver Resection: The Sling Technique for Improved Hepatic Retraction. Ann Surg Oncol. 2025 Jul; 32(7):5021.
    View in: PubMed
    Score: 0.440
  2. CEA Rebound After Discontinuation of Pre-Hepatectomy Chemotherapy Predicts Worse Outcomes After Resection of Colorectal Cancer Liver Metastases. Ann Surg Oncol. 2025 Feb; 32(2):1021-1032.
    View in: PubMed
    Score: 0.429
  3. Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features. Oncologist. 2024 Jun 03; 29(6):e803-e810.
    View in: PubMed
    Score: 0.416
  4. Exceptional pathologic response to preoperative therapy in the context of mutational profiling for colorectal liver metastases. J Gastrointest Surg. 2024 Jul; 28(7):1181-1184.
    View in: PubMed
    Score: 0.414
  5. A Practical Guide to Inflow Control, Retraction, and Exposure for Robotic Hepatectomy. Ann Surg Oncol. 2024 Mar; 31(3):1833.
    View in: PubMed
    Score: 0.401
  6. Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I-II Hepatocellular Carcinoma. Ann Surg Oncol. 2023 Nov; 30(12):7309-7318.
    View in: PubMed
    Score: 0.396
  7. Evaluating the benefit of surgical resection for hepatocellular carcinoma with multifocality or intrahepatic vascular invasion. HPB (Oxford). 2023 07; 25(7):758-765.
    View in: PubMed
    Score: 0.382
  8. Robotic Extended Right Hepatectomy for Colorectal Liver Metastasis. Ann Surg Oncol. 2022 Dec; 29(13):8455.
    View in: PubMed
    Score: 0.370
  9. Robot-assisted liver resection: the real benefit so far. Langenbecks Arch Surg. 2022 Aug; 407(5):1779-1787.
    View in: PubMed
    Score: 0.360
  10. Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection. Ann Surg Oncol. 2022 Aug; 29(8):5156-5164.
    View in: PubMed
    Score: 0.359
  11. ASO Author Reflections: Role of Preoperative Chemotherapy in the Treatment of Pancreatic Neuroendocrine Liver Metastases. Ann Surg Oncol. 2018 12; 25(Suppl 3):792-793.
    View in: PubMed
    Score: 0.282
  12. The evolving concept of conversion surgery for upfront unresectable upper gastrointestinal and hepato-pancreato-biliary cancers: comprehensive review. BJS Open. 2025 Jul 01; 9(4).
    View in: PubMed
    Score: 0.112
  13. Parenchymal-sparing hepatectomy vs single-stage major hepatectomy for bilateral colorectal liver metastases: a higher rate of microscopically positive margins is not associated with increased local recurrence after parenchymal-sparing hepatectomy. J Gastrointest Surg. 2025 Jul; 29(7):102070.
    View in: PubMed
    Score: 0.111
  14. Associations of KRAS Point Mutations with Survival of Patients Who Underwent Curative-Intent Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2025 Apr; 32(4):2425-2434.
    View in: PubMed
    Score: 0.109
  15. Propensity Score-Matched Analysis of Liver Venous Deprivation and Portal Vein Embolization Before Planned Hepatectomy in Patients with Extensive Colorectal Liver Metastases and High-Risk Factors for Inadequate Regeneration. Ann Surg Oncol. 2025 Mar; 32(3):1752-1761.
    View in: PubMed
    Score: 0.108
  16. Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma. Oncology. 2025; 103(6):490-497.
    View in: PubMed
    Score: 0.107
  17. Robotic Hepatic Parenchymal Transection Techniques: A Choice Between Imperfect Tools. Ann Surg Oncol. 2025 Jan; 32(1):438-439.
    View in: PubMed
    Score: 0.107
  18. A propensity score matched cost analysis of robotic versus open hepatectomy. HPB (Oxford). 2024 Nov; 26(11):1379-1386.
    View in: PubMed
    Score: 0.105
  19. Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2024 Apr; 31(4):2547-2556.
    View in: PubMed
    Score: 0.101
  20. Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma. Oncology. 2023; 101(11):730-737.
    View in: PubMed
    Score: 0.099
  21. Incidence of and Risk Factors for Incisional Hernia After Hepatectomy for Colorectal Liver Metastases. J Gastrointest Surg. 2023 11; 27(11):2388-2395.
    View in: PubMed
    Score: 0.098
  22. ASO Author Reflections: The Patient First Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol. 2023 09; 30(9):5401-5402.
    View in: PubMed
    Score: 0.097
  23. Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol. 2023 Sep; 30(9):5390-5400.
    View in: PubMed
    Score: 0.097
  24. Impact of cumulative operative time on postoperative complication risk in simultaneous resections of colorectal liver metastases and primary tumors. HPB (Oxford). 2023 03; 25(3):347-352.
    View in: PubMed
    Score: 0.094
  25. Bintrafusp alfa, an anti-PD-L1:TGF-? trap fusion protein, in patients with ctDNA-positive, liver-limited metastatic colorectal cancer. Cancer Res Commun. 2022 09; 2(9):979-986.
    View in: PubMed
    Score: 0.092
  26. Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases. J Gastrointest Surg. 2022 04; 26(4):791-801.
    View in: PubMed
    Score: 0.087
  27. Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status. Br J Surg. 2021 08 19; 108(8):968-975.
    View in: PubMed
    Score: 0.086
  28. Fast-track two-stage hepatectomy by concurrent portal vein embolization at first-stage hepatectomy in hybrid interventional radiology / operating suite. Surg Oncol. 2021 Dec; 39:101648.
    View in: PubMed
    Score: 0.086
  29. Genomic Sequencing and Insight into Clinical Heterogeneity and Prognostic Pathway Genes in Patients with Metastatic Colorectal?Cancer. J Am Coll Surg. 2021 08; 233(2):272-284.e13.
    View in: PubMed
    Score: 0.085
  30. Preliminary Analysis of Liquid Biopsy after Hepatectomy for Colorectal Liver Metastases. J Am Coll Surg. 2021 07; 233(1):82-89.e1.
    View in: PubMed
    Score: 0.083
  31. Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodes. Surg Oncol. 2021 Mar; 36:138-146.
    View in: PubMed
    Score: 0.082
  32. Alteration of FBXW7 is Associated with Worse Survival in Patients Undergoing Resection of Colorectal Liver Metastases. J Gastrointest Surg. 2021 01; 25(1):186-194.
    View in: PubMed
    Score: 0.081
  33. Short- and Long-Term Outcomes of a Transdiaphragmatic Approach for Simultaneous Resection of Colorectal Liver and Lung Metastases. J Gastrointest Surg. 2021 03; 25(3):641-649.
    View in: PubMed
    Score: 0.081
  34. Impact of the Treating Hospital on Care Outcomes for Hepatocellular Carcinoma. Hepatology. 2018 11; 68(5):1879-1889.
    View in: PubMed
    Score: 0.070
  35. Current Perspectives and Progress in Preoperative Portal Vein Embolization with Stem Cell Augmentation (PVESA). Stem Cell Rev Rep. 2024 07; 20(5):1236-1251.
    View in: PubMed
    Score: 0.026
  36. Reproducibility and efficiency of liver volumetry using manual method and liver analysis software. HPB (Oxford). 2024 07; 26(7):911-918.
    View in: PubMed
    Score: 0.026
  37. Utilizing risk-stratified pathways to personalize post-hepatectomy discharge planning: A contemporary analysis of 1,354 patients. Am J Surg. 2024 Jul; 233:17-23.
    View in: PubMed
    Score: 0.025
  38. Hospital Minimally Invasive Surgery Utilization for Gastrointestinal Cancer. Ann Surg. 2018 08; 268(2):303-310.
    View in: PubMed
    Score: 0.017
  39. Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression [corrected]. Proc Natl Acad Sci U S A. 2010 Jun 15; 107(24):10920-5.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.